Kharge AB, Wu Y, Perlman CE. Surface tension in situ in flooded alveolus unaltered by albumin. J Appl Physiol 117: 440 -451, 2014. First published June 26, 2014 doi:10.1152/japplphysiol.00084.2014.-In the acute respiratory distress syndrome, plasma proteins in alveolar edema liquid are thought to inactivate lung surfactant and raise surface tension, T. However, plasma protein-surfactant interaction has been assessed only in vitro, during unphysiologically large surface area compression (%⌬A). Here, we investigate whether plasma proteins raise T in situ in the isolated rat lung under physiologic conditions. We flood alveoli with liquid that omits/includes plasma proteins. We ventilate the lung between transpulmonary pressures of 5 and 15 cmH2O to apply a near-maximal physiologic %⌬A, comparable to that of severe mechanical ventilation, or between 1 and 30 cmH2O, to apply a supraphysiologic %⌬A. We pause ventilation for 20 min and determine T at the meniscus that is present at the flooded alveolar mouth. We determine alveolar air pressure at the trachea, alveolar liquid phase pressure by servo-nulling pressure measurement, and meniscus radius by confocal microscopy, and we calculate T according to the Laplace relation. Over 60 ventilation cycles, application of maximal physiologic %⌬A to alveoli flooded with 4.6% albumin solution does not alter T; supraphysiologic %⌬A raise T, transiently, by 51 Ϯ 4%. In separate experiments, we find that addition of exogenous surfactant to the alveolar liquid can, with two cycles of maximal physiologic %⌬A, reduce T by 29 Ϯ 11% despite the presence of albumin. We interpret that supraphysiologic %⌬A likely collapses the interfacial surfactant monolayer, allowing albumin to raise T. With maximal physiologic %⌬A, the monolayer likely remains intact such that albumin, blocked from the interface, cannot interfere with native or exogenous surfactant activity. alveolar edema; albumin; plasma proteins; surfactant; surface tension IN THE ACUTE RESPIRATORY DISTRESS syndrome (ARDS), high alveolar-capillary barrier permeability results in pulmonary edema.
IN THE ACUTE RESPIRATORY DISTRESS syndrome (ARDS), high alveolar-capillary barrier permeability results in pulmonary edema. 1 The liquid that floods the alveolus contains plasma proteins that can inactivate lung surfactant by adsorbing faster than surfactant and, once present at the interface, blocking further surfactant adsorption (21, 45, 47, 53) . Plasma proteins have been shown in vitro to increase surface tension, T, in a dose-dependent fashion (18, 41, 42, 45, 53) . Elevated surface tension may, in turn, underlie a decrease in lung compliance in ARDS (29) and thus contribute to the need for mechanical ventilation. Intratracheal delivery of exogenous surfactant has been tested in six randomized, controlled clinical trials as a therapy for ARDS, a means of reversing surfactant inactivation, but has failed to reduce mortality (5) , which remains Ͼ35% (33) .
The evidence for increased surface tension in ARDS stems from the reduced surface activity of bronchoalveolar lavage fluid (BALF) from ARDS patients (14, 18, 19, 32, 34) . This reduced surface activity is principally attributed to protein inactivation of surfactant. However, the surface activity of clinical/experimental ARDS edema liquid and the interaction between plasma proteins and surface tension have been assessed exclusively in vitro in pulsating bubble surfactometers and Langmuir-Wilhelmy balances. During in vitro testing, surface area has been cyclically compressed at varying rates and to varying degrees. The rate of cycling in the presence of proteins appears unimportant, as inactivation occurs at rates ranging from 3 s/cycle to Ͼ3 min/cycle (14, 18, 19, 21, 32, 34, 41, 53) . Inactivation likewise occurs over a range of maximal surface area compressions from 50 to 91% of initial surface area (14, 18, 19, 21, 32, 34, 41, 42, 47, 53) . All of these degrees of compression, however, are unphysiologically large compared with that in the aerated lung. Percent surface area compression (%⌬A ϭ change in surface area/peak surface area) in the lung is 7% for tidal breathing between 40 and 50% of total lung capacity (TLC) and, at most, 32% with a maximal sigh from 40 to 100% of TLC (3, 7) . In the edematous lung, cyclic inflation of grossly-flooded dependent lung units has the potential to impose excessive %⌬A; ventilation with positive end-expiratory pressure (PEEP) may prevent application of excessive %⌬A.
We assess the effect of plasma proteins on surfactant function under physiologic conditions, as follows. In the isolated rat lung, we micropuncture a subpleural alveolus and add proteinaceous solution to the native alveolar liquid phase. The protein solution floods alveoli in the region in which it is instilled. With a thick liquid phase in flooded alveoli, the in situ T determination method (3, (37) (38) (39) (40) of Schürch et al.-requiring microscopic visualization through the pleural surface and the alveolar liquid phase for quantification of fluorocarbon droplet spreading at the alveolar liquid interface-cannot be utilized. Alternatively, we determine T by applying the Laplace relation to the meniscus that forms at the mouth of the flooded alveolus (2, 31) . Combining alveolar air pressure measurement at the trachea of the constantly inflated lung; alveolar liquid phase pressure measurement through a micropipette connected to a servo-nulling pressure-measurement system (23) ; and threedimensional meniscus radius determination by confocal microscopy (31), we introduce a method ( Fig. 1 ) for determining T in situ in the flooded alveolus.
MATERIALS AND METHODS
In flooded alveoli of the isolated rat lung, we investigate plasma protein effects on surface tension under physiologic conditions.
General Preparation
We isolate and control conditions in the rat lung as follows. Isolated rat lung preparation. We handle all animals in accord with a protocol approved by the Stevens Institute of Technology Institutional Animal Care and Use Committee. We prepare the isolated rat lung preparation as described previously but, unless otherwise specified, without perfusion, which does not alter lung mechanics or surfactant function (38, 39, 55) . Briefly, we anesthetize male, Sprague-Dawley rats (n ϭ 50, 200 -425 g) with 1.5-4% isoflurane (Penn Veterinary Supply, Lancaster, PA) in oxygen, inject 1,500 U/kg heparin (Penn Veterinary Supply) by cardiac puncture through the chest wall, and withdraw Ն10 ml blood. We perform a tracheotomy, cannulate the trachea, and continue isoflurane delivery via the trachea. We follow with a median sternotomy and excise the heart and lungs en bloc. We position the lungs with the costal surface upward (55) , connect a pressure transducer at the tracheal entrance to track airway pressure on a monitor, inflate the lungs to a transpulmonary pressure, P ALV, of 30 cmH2O, and then deflate the lungs to a constant PALV of 5 cmH2O. We maintain a moist lung surface throughout the experiment.
In a subset of experiments we perfuse the isolated rat lung, as described previously (55) , to use the vasculature as a route for dye delivery to the alveolar liquid lining layer of the aerated lung. We prepare the lung as above but additionally cannulate the pulmonary artery and the left atrium. We perfuse the isolated lung with 10 ml of autologous blood plus 18 ml of 5% bovine serum albumin (Sigma Aldrich, St. Louis, MO) in normal saline (NS) at 9 ml/min and 37°C. We use this low flow rate to enable dye delivery yet avoid causing edema. We maintain left atrial pressure at 3 cmH2O; pulmonary arterial pressure is 10 cmH2O.
Pressure control. We control lung inflation pressure by passing compressed air through a series of regulators to step down and stabilize pressure. Then, we bleed nearly all flow through a side valve. With the side valve at constant position, inflation pressure is constant (drift range: 0 -0.05 cmH2O/min) and both airway pressure and alveolar air pressure equal P ALV. Alternatively, by manually cycling the degree of side valve opening-opening the valve deflates the lung and closing the valve inflates the lung-we ventilate the lung between target minimum and maximum pressures. We cycle pressure at 0.2 Hz for consistency with a study providing a transpulmonary pressureairway pressure relation from a closed-chest preparation (30) .
Temperature control. We perform experiments at room temperature (18 Ϯ 1°C), 25 Ϯ 0.5°C, or 37 Ϯ 0.5°C. We maintain the lungs at 25°C with a reflective area heater (Kenworld IH9; Home Depot, Atlanta, GA). We maintain the lungs at 37°C by enclosure in a plexiglass steam chamber (Fig. 2) . At all temperatures, we allow the lungs to stabilize for 30 min before commencing experimentation.
Preparation of Alveolar Liquid Phase for Surface Tension Determination
To test the effect of alveolar liquid phase composition on surface tension, we instill a solution of known composition into a subpleural alveolus. We obtain a region of interspersed flooded and aerated alveoli and determine T in both types of alveoli. To determine T in the aerated lung, we include fluorescent dye in the perfusate of the isolated, perfused lung. Dye leaks from the vasculature, fluorescently labeling the liquid lining layer of the aerated lung.
Flooded lung region. With a glass micropipette (tip ID 3-6 m), we puncture an alveolus on the costal lung surface and infuse liquid for 1 min. The liquid floods some but not all alveoli to a distance that extends beyond the margin of the imaging field (31, 52) . Total injection volume is ϳ1.2 l. Some of the flooded alveoli spontaneously clear and others remain stably liquid filled (52) . We are left with a region of interspersed flooded and aerated alveoli, a pattern observed in alveolar edema (44) . With an intact alveolar-capillary barrier, the postinfusion alveolar liquid contains solutes of both the native liquid phase, including native surfactant, and the instilled solution, albeit at uncertain concentrations. Fig. 1 . Surface tension determination method. Image (24-m subpleural depth) of flooded alveolus at transpulmonary pressure, PALV, of 15 cmH2O, obtained with a ϫ10 air objective. Meniscus (solid arc) separates alveolar liquid phase [native liquid phase plus injected 4.6% albumin solution with 2=,7=-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF); green] and air (black). Alveolar walls are also black (arrow). Tip of micropipette (dashed oval) inserted in alveolar liquid phase for pressure measurement by servo-nulling system. Following pipette removal, Z-stack of confocal images of meniscus is obtained (ϫ20 water immersion objective) for determination of meniscus radius. Fig. 2 . Temperature control chamber. Plexiglass steam chamber (10-cm diameter ϫ 3.5-cm height, 5.5-cm diameter hole in top surface) designed to maintain lung at 37°C. Steam is imported from an enclosed water bath through insulated silicone tubing. The silicone tubing leads to one inlet of a Y-connector. Steam escapes through the free port of the Y-connector and an additional port on the far side of the chamber. Pivoting the Y-connector regulates chamber temperature. A plexiglass guard between the steam entry point and the lung protects the lung from direct steam exposure. A thermometer inserted through a port in the chamber wall monitors temperature. Plastic wrap layers cover chamber's top hole and lung surface. Central holes in each plastic wrap layer allow access to lung surface for micropuncture and imaging. During micropuncture, plastic wrap layers are in contact with one another. At all other times, including during imaging with the ϫ20 objective, the top plastic layer seals the top the of chamber.
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To assess the effects of protein content and osmolarity on surface tension, we test the instillation of five liquids: NS; 4.6% albumin in NS; blood plasma that is separated from heparinized whole rat blood by 5 min centrifugation at 5,000 g and should contain ϳ2.7% albumin/6.1% total plasma proteins (10); 28% albumin in NS; and 4.6% 70-kDa dextran (Sigma-Aldrich) in NS. For visualization, we include fluorescent dye in the instilled liquid: 31 M fluorescein (Cole Parmer, Vernon Hills, IL) or 30 M 2=,7=-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF; Life Technologies, Grand Island, NY).
To investigate surfactant function, we alter the instilled liquid as follows. To label surfactant lipids in the alveolar liquid, we add 485 nM FM 4 -64 (Life Technologies) (1) to the instilled liquid. To test the effect of exogenous surfactant, we add 0.9% Survanta (Abbott Nutrition, Columbus, OH) to the instilled liquid. To test the effect of reduced native surfactant content, we lavage the lung with three sequential tracheal instillations of 20 ml fresh NS. Of the total 60 ml saline volume instilled, we retrieve ϳ40 ml. We then reinflate the lung and inject 31 M fluorescein in NS, for fluorescent labeling, into the region in which T is to be determined.
Liquid lining layer of aerated lung. To determine surface tension in an aerated lung, we fluorescently label the liquid lining layer. We prepare the isolated, perfused rat lung and add 23 M fluorescein to the perfusate. The fluorescein labels the vasculature at high intensity but also leaks out of the vasculature to label the alveolar liquid lining layer at lower intensity. During T determination, we pause perfusion.
Data Acquisition and Analysis
Employing pressure measurements and microscopic imaging, we determine surface tension and assess surfactant distribution in the alveolar liquid.
Confocal microscopy. We image subpleural alveoli by confocal microscopy (SP5; Leica Microsystems, Buffalo Grove, IL) using a ϫ20 (0.7 N.A.) water immersion objective without a coverslip, as reported previously (55) . In flooded alveoli, we acquire Z-stacks of 2-m-thick optical sections with a 3-m center-to-center distance between sections. Subpleural imaging depth is 50 -80 m (30 m below top of meniscus). In aerated alveoli, we acquire Z-stacks of 1-m-thick sections with 3 m between sections. Subpleural imaging depth is at least 20 m. Pixel lengths are Յ0.72 and Յ0.36 m for the air-liquid interface and alveolar surfactant, respectively. Excitation/ emission collection wavelengths are 488/490 -540 nm for fluorescein or BCECF and 543/557-775 nm for FM4 -64. To image edema liquid in the absence of dye, we increase laser intensity (30% 488 nm laser) and detector gain (Ͼ1,000 V). We perform image analysis with ImageJ (National Institutes of Health, Bethesda, MD), making length determinations that have been validated against a micrometer.
Alveolar surface tension determination. We calculate interfacial surface tension by applying the Laplace relation, T ϭ (R/2)(P ALV Ϫ PLIQ), across the meniscus of a flooded alveolus (2, 31) or the curved air-liquid interface in an upper corner of a subpleural, aerated alveolus (a corner at which two subpleural septa meet the pleural surface). In this relation, R is interfacial radius of curvature, PALV is alveolar air pressure, and PLIQ is alveolar liquid phase pressure.
During T determination we hold the lung at constant inflation. We record PLIQ through a 2-M saline solution-filled glass micropipette that is connected to a servo-nulling pressure-measurement system (Vista Electronics, Ramona, CA) (23) . We insert the pipette tip (ID 2-4 m) into the liquid phase of a flooded alveolus or the liquid lining layer at the corner of an aerated alveolus (see Figs. 1 and 3) . (In the latter case, we insert the tip through the alveolar wall into the liquid phase, such that the interface remains undisturbed.) To ensure reliability of our PLIQ measurement, we require the PLIQ recording to 1) be stable for 45 s during acquisition and 2) return to 0 Ϯ 0.3 cmH2O upon pipette tip withdrawal into a saline pool on the pleural surface. That PLIQ is found to be positive confirms that the pipette tip is not in the interstitium, where pressure is negative (4) . At the same time as we are measuring P LIQ, we record PALV with the tracheal transducer. Following pressure measurement, we determine R. We obtain a Z-stack of images of the air-liquid interface at the same location at which we have measured P LIQ. Using ImageJ, we mark points along the flooded alveolar meniscus in 5 Ϯ 2 (range 3-9, n ϭ 89) optical sections, from the first section in which the meniscus is evident to the deepest section in which the interface is clearly delineated, or along the interface at the corner of the aerated alveolus in 4 Ϯ 1 (range 3-5, n ϭ 8) optical sections. Using MATLAB (Mathworks, Natick, MA), we fit a sphere to the three-dimensional set of points along the interface (R 2 ϭ 0.98 Ϯ 0.01, n ϭ 97). Radius value does not correlate with the number of planes utilized in radius determination (R 2 ϭ 0.01). To acquire the pressure recordings and images for a single surface tension determination requires 20 min.
To verify that dye inclusion in the alveolar liquid does not alter surface tension, we determine T in control experiments in the absence of dye and in the presence of multiple dyes.
Surfactant distribution. To quantify surfactant distribution in the alveolar liquid phase, we image FM 4 -64 fluorescence and determine the fraction of a given length over which the fluorescence is evident. We track surfactant distribution at the 1) aerated alveolar perimeter, 2) flooded alveolar perimeter, and 3) flooded alveolar meniscus.
Experimental Protocols
We investigate the effect of surface area compression on surfactant function, as follows.
Protocol I: short ventilation protocol with maximal physiologic surface area compression. We apply two cycles of maximal physiologic %⌬A ventilation (pressure variation between 5 and 15 cmH 2O, frequency of 0.2 Hz) and determine T at PALV of 15 cmH2O in one or two alveoli. We apply two additional cycles of maximal physiologic %⌬A ventilation and determine T at PALV of 5 cmH2O. In a subset of experiments (protocol IA), we perform only the first half of this protocol and determine T at only 15 cmH 2O.
Protocol II: long ventilation protocol with maximal physiologic or supraphysiologic surface area compression. We apply two preliminary cycles of maximal physiologic %⌬A ventilation. Then, we follow with 60 cycles of either maximal physiologic %⌬A or supraphysiologic %⌬A (pressure variation between 1 and 30 cmH 2O, frequency of 0.2 Hz) ventilation. During the 60 cycles, we pause at PALV of 15 cmH2O (on deflation during supraphysiologic %⌬A ventilation) at cycles 0 (baseline), 20, 40, and 60 for data acquisition-determination of T or imaging of FM 4 -64. We note that at PALV of 15 cmH2O (deflation), lung volume and lung area are comparable between our maximal physiologic and supraphysiologic %⌬A ventilation protocols (3).
In the protocol II experiments in which we assess surface tension, we attempt to record pressures and image menisci in two alveoli at each time point to ensure surface tension determination in at least one alveolus. We successfully determine surface tension in two alveoli a sixth of the time and average the duplicate results. Due to the time required for surface tension determination, protocol II experiments last 2.2-2.5 h. We match the timing of surfactant distribution experiments to that of surface tension determination experiments. Over this time period, cells remain viable, as indicated by the ability to uptake and retain the dye calcein AM, and alveolar mechanics are unaltered, as indicated by consistent alveolar geometry at a given P ALV.
In Vitro Validation
To validate our T determination method, we apply the same method to a saline drop in vitro. We deposit 3 l of normal saline solution labeled with fluorescein (31 M) on a steel plate. We measure pressure in the saline drop with the servo-nulling pressure-measurement system and determine three-dimensional drop curvature by confocal microscopy. With air pressure equal to zero outside the drop, we calculate T according to the Laplace relation.
Statistics
We assess the accuracy of our T determination method by power analysis. We assess statistical differences by Student's t-test or, for multiple comparisons, ANOVA and Tukey's post hoc analysis, and accept significance at P Ͻ 0.05. Reported errors are standard deviations.
RESULTS

Alveolar Flooding
Liquid instillation floods 42% of subpleural alveoli in the imaged field. In 90% of such alveoli, we observe a meniscus. At P ALV of 15 cmH 2 O, the top of the meniscus is located 41 Ϯ 19 m (n ϭ 32 randomly selected flooded alveoli) below the pleural surface. The remaining 10% of flooded alveoli are liquid filled to a depth beyond our imaging range. As imaging quality is best closest to the pleural surface, we determine surface tension in alveoli in which the top of the meniscuses is located 35 Ϯ 21 m (n ϭ 89 at P ALV of 5 or 15 cmH 2 O) below the pleural surface. Surface tension does not correlate with subpleural meniscus depth (R 2 ϭ 0.01 and 0.001 at P ALV of 5 and 15 cmH 2 O, respectively).
Surface Tension
At P ALV of 5 or 15 cmH 2 O, in the presence or absence of liquid flooding, we determine P LIQ and R. Regardless of lung inflation or liquid flooding, P LIQ averages 1-2 cmH 2 O under all conditions (Table 1) . Liquid flooding does not alter R (Fig. 3) .
Inflation, however, increases R in flooded alveoli. From the values of P ALV , P LIQ , and R, we calculate T.
Inflation from P ALV of 5 to 15 cmH 2 O increases surface tension in flooded alveoli from 2.8 Ϯ 1.1 (n ϭ 43) to 12.0 Ϯ 1.5 (n ϭ 46) mN/m (P Ͻ 0.05; all data from Figs. 5 and 6). That inflation increases T demonstrates that native surfactant is present and functional in our model.
In a subset of experiments, we determine T sequentially in two alveoli without ventilating between determinations. The magnitude of the difference in T between the determinations averages 1 Ϯ 2% (n ϭ 29) of the initial determination T value.
We assess differences in T between experimental groups at high P ALV . At P ALV of 15 cmH 2 O, standard deviation averages 13% of mean value. At 80% power, with n ϭ 4 we can generally detect a 23% difference in T; with n Ͼ 4 we can detect smaller differences in T. At P ALV of 5 cmH 2 O, standard deviation averages 31% of mean value and we generally have insufficient power to distinguish between experimental groups.
We report all subsequent surface tension values normalized by the average T of 12.0 mN/m at P ALV of 15 cmH 2 O.
Experimental Conditions
We find that temperature does not detectably alter T (Fig. 4) and thus report results obtained between room temperature and 25°C. We find that dye inclusion in the alveolar liquid does not alter T (Fig. 5) . 
Effect of Protein Inclusion on Surface Tension
Following protocol I, we find that at P ALV of 15 cmH 2 O T is not altered by alveolar liquid protein content or osmotic pressure. Surface tension is the same in alveoli flooded with 0 -28% albumin solution; blood plasma containing proteins at physiologic concentrations; or 4.6% dextran solution (Fig. 6) . At P ALV of 5 cmH 2 O, 4.6% albumin solution and blood plasma raise T but 28% albumin solution does not. Given the contradictory results between 4.6 and 28% albumin and the generally low power of our method at low inflation, we do not identify a clear trend in the influence of proteins on T at low P ALV .
That protein content does not clearly increase T is surprising. This result is not attributable to an alteration of mechanics in the flooded alveolus, however, as T is the same in aerated and flooded alveoli (Fig. 7) and flooding an alveolus does not alter its compliance (31) .
To explain the difference between our in situ results, in which protein inclusion does not alter T, and in vitro studies, in which protein inclusion more than doubles T, we replicate in situ the large surface area compression of previous in vitro studies (Fig. 8) . Under conditions simulating ARDS-alveolar flooding with 4.6% albumin solution, maximal physiologic %⌬A ventilation-surface tension remains constant over 60 ventilation cycles. With albumin inclusion in the alveolar liquid and supraphysiologic %⌬A ventilation, T rises to a maximal value at ventilation cycle 40. However, with substitution of dextran for albumin, T remains constant over 40 ventilation cycles even with supraphysiologic %⌬A ventilation. Thus only with supraphysiologic %⌬A ventilation does inclusion of the tested albumin concentration raise T. With maximal physiologic %⌬A ventilation, this albumin concentration does not alter T.
Supraphysiologic %⌬A ventilation beyond 40 cycles, regardless of liquid protein content, causes a decline in T (Fig. 8) . Surface tension returns to baseline in the presence of albumin and shows a tendency to decrease below baseline in the absence of albumin. 
Effect of Supraphysiologic Surface Area Compression on Surfactant Distribution
The decline in T beyond 40 cycles of supraphysiologic %⌬A ventilation is associated with an increase in the distribution of surfactant present in the alveolus (Fig. 9 ). At baseline, by light microscopy, we observe discrete surfactant "pools" at the perimeters of aerated and flooded alveoli and at the menisci of flooded alveoli. Following 60 cycles of maximal physiologic %⌬A ventilation, surfactant morphology looks much the same. Following 60 cycles of supraphysiologic %⌬A ventilation, surfactant morphology is markedly altered. Instead of being localized to discrete pools, surfactant is nearly continuously distributed along segments of the alveolar perimeter and of the flooded alveolar meniscus.
Supraphysiologic %⌬A ventilation alters not only surfactant distribution but also liquid distribution, sometimes causing liquid to move from one alveolus to another (Fig. 9Aii) . Such fluid movement during supraphysiologic %⌬A ventilation makes it difficult to track the same menisci over time. Thus the images of Fig. 9 , Ai-Aiii, are paired and the surfactant distribution data of Fig. 9 , B and C, and of the maximum physiologic %⌬A group in Fig. 9D are obtained by tracking the same alveoli over time. However, the images of Fig. 9Aiv are unpaired and the data of the supraphysiologic %⌬A group in 
Method Validation
In situ, we qualitatively validate our T determination method by demonstrating detection of both an increase and a decrease in surface tension at P ALV of 15 cmH 2 O. We display, as control, T for alveoli flooded with 4.6% albumin solution, a model of alveolar edema liquid (Fig. 10) ; we could alternatively have presented data for aerated or saline-flooded alveoli, as T for all of these groups is the same. Following saline lavage, T is elevated by 43 Ϯ 23% (P Ͻ 0.01). With addition of 0.9% Survanta to 4.6% albumin solution, T of flooded alveoli decreases by 29 Ϯ 11% (P Ͻ 0.01) despite the presence of albumin.
In vitro, we quantitatively validate our T determination method. At 25°C, T at the air interface of a normal saline drop should be 72.2 mN/m (27) 
DISCUSSION
We introduce a new method enabling in situ surface tension determination in flooded alveoli. We find that under physiologic conditions addition of albumin to the alveolar liquid does not alter T.
Surface Tension Determination
We investigate the effects of protein content and %⌬A on surface tension primarily at P ALV of 15 cmH 2 O, where lung volume approaches TLC. In a region with homogeneous alveolar flooding, elevated T would hinder ventilation but protect against alveolar overexpansion. In regions of heterogeneous alveolar flooding, however, flooded alveoli are diminished in size and adjacent aerated alveoli are overexpanded to a degree that is proportional to T (31, 44). The aerated alveoli are most overexpanded at peak P ALV . With heterogeneous flooding, elevated T should exacerbate aerated alveolar overexpansion at peak P ALV during mechanical ventilation and reduced T should lessen such overexpansion.
In support of a direct relation between injury and T, we note that the same measure that lowers T, inclusion of Survanta, also reduces dynamic injury to the alveolar-capillary barrier in areas of heterogeneous flooding (54) . This association further indicates that relative differences in T determined by our static method may be related to relative differences in T during dynamic lung ventilation.
The surface tension values that we detect are lower than those reported in the literature. We find T to be 3 and 12 mN/m at P ALV of 5 and 15 cmH 2 O, respectively. Schürch et al. (3, 37, 38) find higher T values: 8, 10, or 14 mN/m at P ALV of 5 cmH 2 O and 21 or 23 mN/m at P ALV of 15 cmH 2 O. The difference between our results is not due to temperature (Fig.  4) , the presence/absence of protein (Figs. 6 and 8) , or the presence/absence of alveolar flooding (Fig. 7) . Both we and Schürch et al. hold the lung at near-constant volume during T determination (thus, as detailed in the APPENDIX, dynamic T has yet to be determined in situ). There are differences between our ventilation protocols and the ways in which we hold the lung at near-constant volume. However, these differences are unlikely to account for the difference in our determined T values.
In our experiments, we determine T directly from the Laplace relation. This method is the same employed to determine T in the pulsating bubble surfactometer (8) . We validate the method with in vitro determination of T in a saline drop yet note that the method is a direct determination that does not require calibration. The accuracy of the method depends on the accuracy with which P ALV , P LIQ , and R are measured. As detailed in MATERIALS AND METHODS, we stably control P ALV and use a micrometer to validate the length calibration of our microscope, with which we determine R. We determine P LIQ with a servo-nulling pressure-measurement system. At P ALV of 5 or 15 cmH 2 O, regardless of flooding, we find P LIQ to average between 1.0 and 2.1 cmH 2 O. These P LIQ values are consistent with previous reports. Between P ALV of 5 and 15 cmH 2 O, flooded alveolar P LIQ has been found to average 1 to 3.3 cmH 2 O in the presence of mild edema, whether due to intratracheal saline instillation, oleic acid administration, or elevated hydrostatic pressure (9, 23, 24 Table 1 ). The discrepancy in T determination by Laplace application as opposed to the microdroplet method requires further investigation. Here, we focus on identifying relative differences in T at high P ALV , which should affect the degree of ventilation-induced alveolar overexpansion injury.
Protein-Native Surfactant Interaction In Situ
We find that neither albumin, at 4.6 or 28%, nor all plasma proteins together, at physiologic concentration, inactivate native surfactant following two cycles of maximal physiologic %⌬A ventilation. Our method is not sensitive enough to detect small differences in T that might exist between the experimental groups of Fig. 6 . Protein addition to surfactant in vitro typically causes more than a doubling of T (14, 18, 19, 21, 47) , however, which would be detectable by our method. In situ, we do not observe protein addition to induce such a large change in T.
As proteins in the instilled liquid likely diffuse away from the flooded region into the liquid lining layer of surrounding alveoli, we do not know the protein concentration of the alveolar liquid for which we determine T. With instillation of 28% albumin solution, however, the albumin concentration remaining in the alveolar liquid following diffusive efflux likely exceeds the high end of the physiologic range, ϳ4.5%. Furthermore, with instillation of 4.6% albumin solution, sufficient albumin remains present following any diffusive efflux to raise T after 40 cycles of supraphysiologic %⌬A ventilation (Fig. 8) . Although the albumin content of the alveolar liquid for which we determine T is uncertain, the albumin concentrations that we test should encompass the physiologic range.
The longest duration over which we track T is 60 cycles, and we do so only following instillation of 4.6% albumin solution. With 4.6% albumin solution and maximal physiologic %⌬A ventilation, T remains constant over 60 cycles but might increase at a later time. We test 28% albumin solution and other plasma proteins after only two cycles of maximal physiologic %⌬A ventilation and do not know whether T might increase at a later time. In vitro data, however, suggest that any protein inactivation of surfactant should be immediately apparent. When plasma protein-lung surfactant mixtures are tested in vitro, protein inactivation of surfactant is observed during initial adsorption (18, 21, 41) as well as at all time points, ranging from cycle 1 to cycle 200, of supraphysiologic surface area compression (14, 18, 19, 21, 41, 42, 47) . That inactivation is present during initial adsorption in vitro suggests that the degree of applied %⌬A is not the only difference between in vitro and in situ experiments.
The BALF tested in vitro contains lamellar surfactant structures and tubular myelin (16, 49, 50) but not, initially, a surfactant monolayer. In the absence of an initial monolayer in vitro, there is competitive adsorption between surfactant and plasma proteins (18, 21, 41) . Once a monolayer forms in vitro, its presence blocks plasma proteins injected into the subphase from adsorbing and raising T (21) . In situ, an intact surfactant monolayer is presumably present before alveolar flooding and T remains low following flooding with proteinaceous solution. Accordingly, we interpret our 60 cycle experiments as follows.
With maximal physiologic %⌬A ventilation, the surfactant monolayer likely maintains its integrity, such that T remains unaltered. Supraphysiologic %⌬A ventilation likely collapses the monolayer, allowing albumin in the alveolar liquid to adsorb to the interface and increase T. Hydrophilic dextran, in contrast, appears to remain in the bulk liquid phase even during supraphysiologic %⌬A ventilation, such that its presence does not alter T. In situ, as in vitro (21), albumin may raise T only in the absence of an intact surfactant monolayer.
While we typically use albumin as a representative plasma protein, it is not the most inhibitory plasma protein. Relative to phospholipid concentration, lower concentrations of some other plasma proteins are required to cause maximal surfactant inactivation in vitro (42) . Albumin is maximally inactivating at a protein-to-phospholipid ratio of 12 and fibrinogen at a ratio of just 6 (42) . However, albumin is the most abundant plasma protein. Considering protein concentrations in the plasma, 4.5% or 45,000 g/ml for albumin, 0.3% or 3,000 g/ml for fibrinogen, as the upper limits for concentrations of the same proteins in ARDS edema liquid and estimating edema liquid phospholipid concentration to be ϳ2,000 g/ml 2 in ARDS, we estimate an edema liquid albumin-to-phospholipid ratio of 22 and fibrinogen-tophospholipid ratio of 1.5. That is, we estimate the edema liquid albumin and fibrinogen concentration to be 180 and 25%, respectively, of the maximally inactivating albumin and fibrinogen concentrations. Globulins are both present at a lower concentrations and less inhibitory than albumin (42) . Based on in vitro dose-response curves, albumin may, due to its high concentration, be the plasma protein with the greatest potential to interfere with in vivo surfactant activity.
Surface Area Compression
In simulating maximal physiologic %⌬A ventilation, we vary P ALV between 5 and 15 cmH 2 O. From a relation between P ALV and airway pressure in the nondependent, closed-chest dog lung (30) , this maximal physiologic %⌬A ventilation protocol is equivalent to mechanical ventilation with a minimum airway pressure, or PEEP, of 3 cmH 2 O and a peak inspiratory airway pressure of 20 cmH 2 O. Using rat data of Schürch et al. (39) to relate P ALV to lung volume and rabbit data of Bachofen et al. (3;  light microscopy data set) to relate lung volume to surface area-and noting that surface area compression is similar across a range of species sizes (3, 7)-this ventilation protocol varies volume between 47 and 90% of TLC and applies a %⌬A of ϳ23%. Mechanical ventilation with a PEEP of 5 cmH 2 O and lung expansion to 100% of TLC would likewise apply a %⌬A of ϳ23%. In mild ARDS, albumin in the edema liquid might not alter T in vivo.
The %⌬A applied by ventilation between 1 and 30 cmH 2 O is unknown but exceeds the 32% of ventilation between 40 and 100% TLC (3, 7) . The applied %⌬A is sufficient to enable albumin inclusion to increase T but only transiently. In mild ARDS, this %⌬A would be supraphysiologic.
In severe ARDS there is gross flooding of the dependent lung beyond the alveolar level into the airways (44) . In the 2 Edema liquid phospholipid concentration estimated from data of Günther et al. (18) as (ϳ28 g phospholipid/ml in ARDS BALF) times (62 g SP-B/ml in ARDS edema liquid, as determined by urea concentration correction of SP-B content in BALF) divided by (0.867 g SP-B/ml in ARDS BALF). grossly-flooded dependent lung, the relation between mechanical ventilation and surface area compression is more complex. Low PEEP ventilation has the potential to apply excessive %⌬A. With low or no PEEP there is cyclic recruitment of dependent lung units, as has been observed in computedtomography studies (26, 30) and modeled in vitro (13) . In these units, interfacial surface area may vary between the area of a meniscus across an airway at minimum P ALV and, with inflation, nearly full alveolar surface area at maximum P ALV . With this degree of %⌬A, plasma proteins may increase T. Alternatively, this degree of %⌬A may increase surfactant distribution sufficiently to offset an increase in T. Use of sufficient PEEP may avoid application of such excessive %⌬A altogether.
Interfacial Surfactant Distribution
With supraphysiologic %⌬A ventilation, we observe increased surfactant distribution around the alveolus (Fig. 9) . Whether the increased distribution is due to increased secretion and/or spreading is unknown. We note, however, that secretion should be marked even with maximal physiologic %⌬A ventilation.
In imaging surfactant in the alveolar liquid phase, we employ light microscopy and visualize large surfactant "pools." To determine whether the pools contain tubular myelin or to resolve the interfacial monolayer would require the resolution of electron microscopy. In aerated alveoli, given the oblique intersection between imaging plane and liquid lining layer, we cannot always distinguish whether surfactant pools are located at the interface or alveolar wall. Nonetheless, the supraphysiologic %⌬A-induced increase in surfactant distribution that we observe is associated with a reduction in surface tension.
Exogenous Surfactant Concentration
We find that 0.9% Survanta, or 0.23 mg phospholipids/ml, added to proteinaceous alveolar liquid decreases T by 29%. This phospholipid concentration is an order of magnitude lower than the 50 -100 mg phospholipid/kg clinical concentration that has been tested in ARDS (15, 43) . Consider administration of 50 mg phospholipid/kg to a 70-kg person with a functional residual capacity (FRC) of 2,000 ml. If 40% of the airspace were liquid flooded at FRC, then the resultant exogenous phospholipid concentration would be ϳ4 mg/ml. If the lungs were less edematous, the exogenous phospholipid concentration could be greater.
Protein Content and Surface Tension of Bronchoalveolar Lavage Fluid in ARDS
The belief that plasma proteins in the alveolar edema liquid raise T in ARDS stems from studies of BALF from ARDS patients. In these studies, BALF is fractionated by low-speed centrifugation (100 -500 g) to eliminate cells and, in some cases, further high-speed centrifugation (Ն40,000 g) or equivalent sucrose gradient separation (14, 18, 19, 32, 34, 51) . The high-speed centrifugation pellet, or equivalent sucrose gradient fraction, from ARDS patients has, relative to that from control patients, an elevated protein content (14) ; an elevated proteinto-phospholipid ratio (14, 51) ; and elevated minimum T, as determined by in vitro testing (14, 18, 19) . The low-speed centrifugation supernatant from ARDS patients has, relative to that from control patients, an elevated protein content (18, 34, 51) ; an elevated protein-to-phospholipid ratio (18) ; and reduced surface activity, as indicated by reduced hysteresis area or reduced surfactant film elasticity (32, 34) . [Minimum T of the low-speed centrifugation supernatant is high even for control subjects and not further elevated for ARDS patients (32, 34) , likely because the protein-to-phospholipid ratio of the low-speed centrifugation supernatant from control subjects is sufficiently high, in fact comparable to that of the high-speed centrifugation pellet from ARDS patients, as to be inactivating (51) .] Thus the assumption that plasma proteins inactivate surfactant in ARDS is based on an association between protein content and surface activity of BALF from ARDS patients. In these clinical studies (14, 18, 19, 32, 34) and related experimental studies (21, 41, 42, 47, 53) , however, surface area compression during T determination has exceeded 50%, weakening relevance to a physiologic scenario.
Other Potential Mechanisms of Surfactant Inactivation in ARDS
Our results suggest that during application of maximal physiologic %⌬A ventilation albumin and plasma proteins may not inactivate surfactant in vivo. However, surfactant function in ARDS may be impaired by other means, as detailed below.
1) Surfactant amount may decrease, as is indicated by quantitative (urea concentration-corrected) BALF samples (18) . Interfacial area should also be reduced with alveolar flooding, however, and it is not known how interfacial surfactant concentration changes.
2) Altered surfactant phospholipid composition may impair surface activity. In BALF from ARDS patients, the relative fractions of phosphatidylcholine (PC) and phosphatidylglycerol (PG) are decreased while the relative fractions of phosphatidylinositol (PI), phosphatidylethanoalamine (PE), sphingomyelin (SM), and lysoPC are increased (14, 18, 19, 34, 51) . Furthermore, the composition of fatty acid chains among the phospholipids is altered. Fatty acid chains are less saturated such that the fraction of disaturated phospholipids is reduced (19) . Enzymatic imbalance may contribute to the altered relative phospholipid concentrations in ARDS. Relative to BALF phospholipid content, there is a decrease in activity of phosphatidate phosphatase, which generates PC, and an increase in activity of phospholipase A 2 (PLA 2 ), which degrades PC to lysoPC and PG to lysoPG (19, 20) . However, phosphatidate phosphatase also generates PE, which increases in ARDS, and following PLA 2 degradation of any glycerophospholipid, including PI and PE whose relative fractions increase in ARDS, there may be either reacylation or degradation (20) . Thus further investigation is required.
3) Quantities of surfactant protein (SP)-A and SP-B may be decreased in BALF from ARDS patients. Relative to phospholipid quantity, SP-A and SP-B quantities in whole BALF and the low-and high-speed centrifugation pellets are decreased (14, 51) . Furthermore, in the low-speed centrifugation supernatant, the urea concentration-corrected quantity of SP-A is decreased (18) .
4) Surfactant may be converted from its tubular myelin-and lamellar body-containing, highly surface active, large aggregate form found in the high-speed centrifugation pellet into its unilamellar vesicular, less surface active, small aggregate form found in the high-speed centrifugation supernatant (16, 56) .
The fractional amount of the small aggregate form tends to increase in ARDS (18, 51) . Conversion is attributed to surface area compression and effected in vitro by a compression of 80% (17, 48 -50) . However, whether a %⌬A Ͻ 80% can cause conversion is not known. Furthermore, while the quantity of small aggregates increases transiently during ventilation with combined high tidal volume and respiratory rate, the quantity of large aggregates remains unchanged (35) . This result suggests that the quantity of surface active large aggregates is tightly controlled. Conversion may be part of the surfactant degradation/recycling process, but in vivo there is concurrent secretion of new surfactant.
Several of the above scenarios may be influenced by the presence in BALF of membrane fragments from destroyed cells. Addition of cell membrane phospholipids to the BALF phospholipid pool would explain the relative decrease of surfactant proteins. Furthermore, cellular membrane fragments might locate to the high-speed centrifugation supernatant along with small surfactant aggregates. The contribution of cell membrane phospholipids to the altered phospholipid composition in BALF from ARDS patients requires further study and whether any of the above mechanisms impair native surfactant function in ARDS remains unknown. Excepting potential enzymatic alteration of surfactant phospholipids, however, the above mechanisms would not be expected to interfere with exogenous surfactant activity.
Lung Compliance in ARDS
Could preserved surfactant function in ARDS be consistent with reduced lung compliance (29) ? First, in acute reversible high pressure edema, compliance is reduced (6) . This condition is presumably caused by interstitial edema. Surface tension should remain normal and reduced compliance may be attributable to tissue turgidity. Second, in prolonged high pressure edema, when T should likewise remain normal, compliance is further reduced (6) . The latter scenario may be explained by differential mechanics between aerated and flooded regions. On a gross scale, computed tomography demonstrates that tidal volume preferentially expands the aerated, nondependent lung (46); the flooded, dependent lung is largely noncompliant, which would reduce total lung compliance. Furthermore, even low tidal volume ventilation can, in this situation, overexpand the nondependent lung (46) , such that compliance of the nondependent lung is also reduced. On the microscale it is evident that, with gross-dependent flooding, the nondependent lung contains interspersed aerated and flooded alveoli (44) . With heterogeneous flooding and normal T, flooded alveoli maintain normal compliance but shrink in size (31) . Neighboring aerated alveoli are consequently overexpanded and, due to the nonlinear parenchymal stress-strain relation, operate in a region of reduced compliance. Reduced compliance in a fraction of the nondependent lung contributes to the reduced net compliance of the nondependent lung. With normal T, compliance can be reduced in the edematous lung.
Methodologic Limitations
We summarize here the limitations of our surface tension determination method. Despite the association between static and dynamic (54) tests, the static nature of our method and the long, 20-min time period required to determine T are major limitations. The other major limitation is the low precision of the method. The accuracy of our T determination depends on the accuracy of P ALV , P LIQ , and R measurement. As we measure P ALV with high precision, the ratio of the standard deviation in P LIQ to the difference (P ALV Ϫ P LIQ ), ϳ5% at P ALV of 15 cmH 2 O (Table 1) , is one source of error in determined T. The ratio of standard deviation in to mean value of R, ϳ10% at P ALV of 15 cmH 2 O, is the other principal source of error in determined T. That we assume a spherical interfacial curvature, rather than determine whether curvature differs along principals axes of the interfacial surface, may contribute to the error in R. It is due to these measurement errors that, as detailed in the RESULTS, at P ALV of 15 cmH 2 O we can typically detect only differences in T that exceed 23%. At P ALV of 5 cmH 2 O, measurement errors are greater and we typically cannot detect differences in T.
We further determine T in what may be considered a model of mild ARDS, in that cyclic surface area compression is comparable to that of the aerated lung. In this model, we find that albumin inclusion in alveolar flooding liquid does not alter surface tension. With low PEEP ventilation of a severe ARDS model, cyclic recruitment of grossly-flooded dependent lung units would be expected to impose an excessive %⌬A. In this scenario, it remains to be determined whether plasma proteins could cause a sustained increase in T or whether the excessive %⌬A would, through increased surfactant spreading, maintain normal or even depressed surface tension.
Conclusions
In a model of mild ARDS, we demonstrate that albumin inclusion in alveolar liquid interferes with neither native nor exogenous surfactant function. Comparing the present in situ investigation to previous in vitro studies, we interpret that an intact surfactant monolayer in our preparation maintains its integrity during maximal physiologic %⌬A ventilation and excludes albumin from the interface. This interpretation requires direct testing. Furthermore, our finding that exogenous surfactant can lower surface tension by 29% in the presence of albumin is supportive of surfactant therapy as a treatment for ARDS. Determining the reasons for clinical surfactant therapy inefficacy remains warranted.
APPENDIX
Neither we nor Schürch et al. (38, 39) determine dynamic T in the lung. In our experiments, we ventilate the lung at physiologic frequency and then hold P ALV constant for 20 min while determining T. Schürch et al. (38, 39) ventilate the lung at low frequency and then hold constant the number of gas molecules in the lung during T determination. In both cases, we wonder what might be the effects of stress relaxation and of T reversion to equilibrium (36) .
To gauge whether stress relaxation causes an increase or decrease in T, we note that P ALV balances a combination of tissue tension, TT, and surface tension. In a linear approximation,
where C indicates a constant. Furthermore, tissue tension is proportional to tissue distension:
T ϭ ␣V 2⁄3 ,
with ␣ another proportionality factor. Combining Eqs. 1-3 and letting ␥ ϭ C1␥ and␣ ϭ C2␣, we obtain the relation␥ ϭ PALV/V 1/3 Ϫ␣V 1/3 . Differentiation with respect to V yields the relation ‫‪V‬ץ/␥ץ‬ ϭ Ϫ PALV/(3V 4/3 ) Ϫ␣/(3V 2/3 ). With constant PALV in our experiments, stress relaxation-a decrease in␥-will tend to increase V and consequently, according to Eq. 3, increase T. In the experiments of Schürch et al. (38, 39) in which the number of gas molecules in the lung is constant,
In this case, from Eqs. 1-4,␥ ϭ C 3/V 4/3 Ϫ␣V 1/3 and ‫‪V‬ץ/␥ץ‬ ϭ Ϫ4C3/(3V 7/3 ) ϭ␣/(3V 2/3 ). Stress relaxation will likewise tend to increase V and, consequently, increase T, albeit at a different rate than in our experimental preparation.
Reversion to equilibrium causes T, at constant area, to move toward an equilibrium value, T EQ, of ϳ24 mN/m (36) . At PALV of 5 or 15 cmH2O in our experiments and the experiments of Schürch et al., T Ͻ TEQ and reversion to equilibrium should tend to increase T.
Stress relaxation and reversion to equilibrium may influence T during different phases of our experiments and the experiments of Schürch et al. We ventilate the lung at 5 s/cycle then arrest ventilation and require 20 min to determine T. In our experiments, T likely increases between ventilation arrest and T determination. Schürch et al. (3, 37, 38) deflate the lung either stepwise, pausing Ն2 min after each step, or continuously at ϳ8 min/cycle. At such low frequencies, both stress relaxation and reversion to equilibrium can begin to occur during ventilation such that they influence dynamic T at the time of ventilation arrest (22, 25) , perhaps explaining why Schürch et al. (38, 40) find T at TLC to be the same whether pausing ventilation for seconds, or minutes, before T determination.
Furthermore, the timing of stress relaxation and reversion to equilibrium may be different. Schürch et al. (37, 40) observe a late rise in T that is accompanied by an increase in P ALV and thus also, according to Eq. 4, a decrease in V. That the rise in T is accompanied by a decrease in V indicates it is the result of reversion to equilibrium. The late occurrence of this rise in T suggests that reversion to equilibrium may have a long time constant. Our concern here is how T changes before initial T determination and stress relaxation, in particular, may alter T rapidly.
In both our experiments and the experiments of Schürch et al., stress relaxation and reversion to equilibrium tend to increase T. We conclude that dynamic T is lower than T as determined by either static method, but the degree to which dynamic T is lower is unknown.
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